Is Bachem Holding AG (BCHMF) a Buy, Sell, or Hold?
OTC : BCHMF
Bachem Holding AG
$87.34 USD
$0 (0.0%)
- Volume
- 1K
- Average Volume
- 23
- Market Capitalization
- $6.54B
- P/E Ratio
- 37.79
- Dividend Yield
- 1.20%
- Price Target
- Year High
- $94.62
- Year Low
- $60.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.21
- Current Ratio
- $1.79
Company Overview
OTC
Anne-Kathrin Stoller
Drug Manufacturers - Specialty & Generic
Healthcare
BCHMF
2511
CH
USD
Liquidity Metrics
0.04
1.79
0.57
0.08
0.21
Sales & Valuation
$695.4M
8.11
3.87
-116.91
-0.64
Profitability
$1.98
$148.86M
21.41%
22.50%
10.56%
7.06%
P/E Metrics
37.79
1.55
1.55
Analyst Price Target & Rating
3/5
2 Analysts
%
Financial Health Scores
6.73
4/9
$321.47M
$2.11B
$650.72M
$286.1M
Key Metrics (TTM)
$5.29B
7.61
29.42
1.79
10.56%
8.12%
2.83%
-0.92%
$29.48
432 days
Company Executives
| Name | Title |
|---|---|
| Torsten Wohr | Chief Commercial Officer |
| Achim Pluckebaum | Chief Information Officer |
| Alain Schaffter | Chief Financial Officer |
| Barbora Blaha | Head of Investor Relations |
| Viviane Minden | Chief Human Resources Officer |
| Anne-Kathrin Stoller | CEO & CCO |
| Boris Corpataux | Vice President & Head Global Strategic Alliances |
| Michael Suter | Vice President of Global Accounting |
| Hans van Hees | Chief Operations Officer |
| Daniel Grotzky | Head of Group Communications |
| Gunther Loidl | Chief Technology Officer |
Poll Results
No votes yet today — be the first to share your view!
About Bachem Holding AG (OTC:BCHMF) Stock
Bachem Holding AG is a global partner to pharmaceutical and biotechnology companies, supplying crucial products and services for every stage from early-stage research and clinical trials to full-scale commercialization. The company specializes in the creation, manufacturing, and regulatory assistance for peptide active pharmaceutical ingredients (APIs), particularly novel peptide and oligonucleotide chemical entities (NCEs). Beyond these, Bachem also offers established commercial NCEs and generic medications. Its comprehensive service offerings include project oversight, quality assurance, regulatory compliance guidance, advanced analytical testing, GMP-compliant production, specialized research-grade manufacturing, and integrated supply chain solutions. The company, established in 1971, o ... perates from its headquarters in Bubendorf, Switzerland.
Frequently Asked Questions
-
What is the current Bachem Holding AG (BCHMF) stock price?
-
Bachem Holding AG(OTC:BCHMF) stock price is $87.34 in the last trading session. During the trading session, BCHMF stock reached the peak price of $94.62 while $60.51 was the lowest point it dropped to. The percentage change in BCHMF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BCHMF stock was $0.
-
BCHMF's industry and sector of operation?
-
The OTC listed BCHMF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of BCHMF?
-
Torsten Wohr | Chief Commercial Officer
Achim Pluckebaum | Chief Information Officer
Alain Schaffter | Chief Financial Officer
Barbora Blaha | Head of Investor Relations
Viviane Minden | Chief Human Resources Officer -
How many employees does BCHMF have?
-
Number of BCHMF employees currently stands at 2511. BCHMF operates from Hauptstrasse 144, Bubendorf, BL 4416, CH.
-
Link for BCHMF official website?
-
Official Website of BCHMF is: https://www.bachem.com
-
How do I contact BCHMF?
-
BCHMF could be contacted at phone #41 58 595 2021 and can also be accessed through its website. BCHMF operates from Hauptstrasse 144, Bubendorf, BL 4416, CH.
-
How many shares of BCHMF are traded daily?
-
The average number of BCHMF shares traded daily for last 3 months was 23.
-
What is the market cap of BCHMF currently?
-
The market value of BCHMF currently stands at $6.54B with its latest stock price at $87.34